Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Nat Immunol. 2022 Apr;23(4):632-642. doi: 10.1038/s41590-022-01152-y. Epub 2022 Mar 17.
Although inhibition of T cell coinhibitory receptors has revolutionized cancer therapy, the mechanisms governing their expression on human T cells have not been elucidated. In the present study, we show that type 1 interferon (IFN-I) regulates coinhibitory receptor expression on human T cells, inducing PD-1/TIM-3/LAG-3 while inhibiting TIGIT expression. High-temporal-resolution mRNA profiling of IFN-I responses established the dynamic regulatory networks uncovering three temporal transcriptional waves. Perturbation of key transcription factors (TFs) and TF footprint analysis revealed two regulator modules with different temporal kinetics that control expression of coinhibitory receptors and IFN-I response genes, with SP140 highlighted as one of the key regulators that differentiates LAG-3 and TIGIT expression. Finally, we found that the dynamic IFN-I response in vitro closely mirrored T cell features in acute SARS-CoV-2 infection. The identification of unique TFs controlling coinhibitory receptor expression under IFN-I response may provide targets for enhancement of immunotherapy in cancer, infectious diseases and autoimmunity.
虽然抑制 T 细胞共抑制受体已经彻底改变了癌症治疗方法,但它们在人类 T 细胞上的表达机制尚未阐明。在本研究中,我们表明,I 型干扰素(IFN-I)调节人类 T 细胞上的共抑制受体表达,诱导 PD-1/TIM-3/LAG-3,同时抑制 TIGIT 表达。IFN-I 反应的高时间分辨率 mRNA 分析建立了揭示三个时间转录波的动态调控网络。关键转录因子(TF)的扰动和 TF 足迹分析揭示了两个具有不同时间动力学的调控模块,它们控制共抑制受体和 IFN-I 反应基因的表达,其中 SP140 被突出为区分 LAG-3 和 TIGIT 表达的关键调节因子之一。最后,我们发现体外的动态 IFN-I 反应与急性 SARS-CoV-2 感染中的 T 细胞特征非常相似。在 IFN-I 反应下控制共抑制受体表达的独特 TF 的鉴定可能为癌症、传染病和自身免疫中的免疫疗法增强提供了目标。